His results indicate a CD4 count of 150 cells/mm3
A 38-year-old man returns to his physician’s office to find out about recent test results. His results indicate a CD4 count of 150 cells/mm3 and an HIV RNA of 75,000 copies/mL, which are similar to lab results from tests conducted a month ago, confirming that the patient is HIV positive. The patient is currently taking trimethoprim-sulfamethoxazole as prophylaxis for Pneumocystis jiroveci pneumonia. Following a thorough discussion of treatment options, the patient and physician agree that initiating antiretroviral therapy would be the best plan of action, and a regimen of tenofovir-emtricitabine (300 mg and 200 mg, respectively, qd) plus darunavir-ritonavir (100 mg and 800 mg, respectively, qd) is most appropriate. The patient fills his prescription at the nearest specialty HIV pharmacy. The pharmacist, knowing that the patient is new, takes the patient into a private room to discuss important treatment information.